August 6, 2012
Academic Researchers Escape Scrutiny in Glaxo Fraud Settlement
Toby Melville, Reuters, Newscom
Federal prosecutors triumphantly announced the nation's largest-ever health-care-fraud settlement last month, when the pharmaceutical maker GlaxoSmithKline admitted marketing its drugs for unapproved purposes.
Virtually unpublicized was a key detail: One of the central pieces of evidence in the case was a 2001 scientific journal article listing 22 authors, most of them university researchers, that was actually written by Glaxo-hired authors to overstate the benefits and understate the